微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 1.49% | -57.91% | 525.71% | 69/141 | 2.01% | 惠泰医疗 | 15.7% | 行业排名> |
| 2026-03-31 | -0.35% | -125.55% | -111.48% | 103/141 | 1.2% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | 3.05% | -50.57% | -35.38% | 66/141 | 2.37% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | 4.72% | 9.26% | 33.33% | 60/141 | 4.19% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 3.54% | 61.64% | 158.39% | 48/141 | 2.43% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 1.37% | 92.96% | -77.8% | 60/141 | 1.42% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 6.17% | 122.74% | 42.82% | 53/141 | 4.14% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 4.32% | 254.1% | 97.26% | 65/141 | 5.03% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 2.19% | 3028.57% | 208.45% | 78/141 | 3.15% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 0.71% | 191.03% | -74.37% | 83/141 | 1.75% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 2.77% | -61.63% | 127.05% | 88/141 | 5.44% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 1.22% | -85.44% | 1642.86% | 102/141 | 6.06% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 0.07% | -98.96% | 108.97% | 114/141 | 3.96% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | -0.78% | -118.93% | -110.8% | 115/141 | 2.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-12-31 | 7.22% | -63.16% | -13.84% | 80/141 | 13.33% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 8.38% | -51.7% | 25.07% | 65/141 | 13.94% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 6.7% | -42.78% | 62.62% | 57/141 | 9.74% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 4.12% | -29.57% | -78.98% | 36/141 | 6.8% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 19.6% | 30.67% | 12.97% | 41/141 | 18.45% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 17.35% | -1.53% | 48.16% | 34/141 | 16.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 11.71% | -19.9% | 100.17% | 40/141 | 11.59% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 5.85% | 7.93% | -61% | 31/141 | 6.49% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 15% | -14.58% | -14.87% | 64/141 | 26.27% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 17.62% | 43.14% | 20.52% | 30/141 | 19.98% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 14.62% | 121.18% | 169.74% | 30/141 | 15.17% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 5.42% | 502.22% | -69.13% | 17/141 | 3.31% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 17.56% | -20.65% | 42.65% | 48/141 | 14.66% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 12.31% | 2% | 86.23% | 22/141 | 10.54% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 6.61% | 1.23% | 634.44% | 28/141 | 6.76% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 0.9% | 2% | -95.93% | 44/141 | 2.73% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 22.13% | 8.91% | 8.91% | 25/141 | 14.23% | 安旭生物 | 48.71% | 行业排名> |
| 2017-12-31 | 20.32% | 28.45% | 211.18% | 25/141 | 14.51% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2017-06-30 | 6.53% | 116.94% | -58.72% | 26/141 | 6.11% | *ST明德 | 14.54% | 行业排名> |
| 2016-12-31 | 15.82% | 59.48% | 425.58% | 34/141 | 16.44% | 迈瑞医疗 | 11% | 行业排名> |
| 2016-06-30 | 3.01% | 2% | -69.66% | 38/141 | 6.35% | 安旭生物 | 59.22% | 行业排名> |